160 related articles for article (PubMed ID: 23886504)
1. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
[TBL] [Abstract][Full Text] [Related]
3. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
4. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
[TBL] [Abstract][Full Text] [Related]
5. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
[TBL] [Abstract][Full Text] [Related]
7. An HIV-1 integrase genotype assay for the detection of drug resistance mutations.
Hearps AC; Greengrass V; Hoy J; Crowe SM
Sex Health; 2009 Dec; 6(4):305-9. PubMed ID: 19917199
[TBL] [Abstract][Full Text] [Related]
8. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
[TBL] [Abstract][Full Text] [Related]
9. Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.
Seatla KK; Choga WT; Mogwele M; Diphoko T; Maruapula D; Mupfumi L; Musonda RM; Rowley CF; Avalos A; Kasvosve I; Moyo S; Gaseitsiwe S
PLoS One; 2019; 14(11):e0224292. PubMed ID: 31751353
[TBL] [Abstract][Full Text] [Related]
10. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization of HIV-1 Minority Subtypes in Hong Kong: A Recent Epidemic of CRF07_BC among the Men who have Sex with Men Population.
Leung KS; To SW; Chen JH; Siu GK; Chan KC; Yam WC
Curr HIV Res; 2019; 17(1):53-64. PubMed ID: 31142258
[TBL] [Abstract][Full Text] [Related]
12. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.
Kim JY; Kim EJ; Choi JY; Kwon OK; Kim GJ; Choi SY; Kim SS
Clin Microbiol Infect; 2011 Aug; 17(8):1155-9. PubMed ID: 20946407
[TBL] [Abstract][Full Text] [Related]
15. A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
Van Laethem K; Schrooten Y; Covens K; Dekeersmaeker N; De Munter P; Van Wijngaerden E; Van Ranst M; Vandamme AM
J Virol Methods; 2008 Nov; 153(2):176-81. PubMed ID: 18706932
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; D'Arrigo R; Gori C; Perno CF; Colizzi V; Nanfack A; Gwom LC; Cappelli G; Takou D
Arch Virol; 2011 Jul; 156(7):1235-43. PubMed ID: 21465085
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
[TBL] [Abstract][Full Text] [Related]
18. Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
Nouhin J; Donchai T; Hoang KT; Ken S; Kamkorn J; Tran T; Ayouba A; Peeters M; Chaix ML; Lien TX; Nerrienet E; Ngo-Giang-Huong N
Infect Genet Evol; 2011 Jan; 11(1):38-43. PubMed ID: 21094281
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
[TBL] [Abstract][Full Text] [Related]
20. The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.
Malet I; Fourati S; Charpentier C; Morand-Joubert L; Armenia D; Wirden M; Sayon S; Van Houtte M; Ceccherini-Silberstein F; Brun-Vézinet F; Perno CF; Descamps D; Capt A; Calvez V; Marcelin AG
J Antimicrob Chemother; 2011 Dec; 66(12):2827-30. PubMed ID: 21933786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
